Pharmhouse Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q4 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +170,983,900.0% | -112.4% | – | – | – | -102.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | – | |
| – | -17.0% | -83.1% | -61.2% | -3,242.2% | – | -99.7% | +122.5% | +2,042.3% | -283.5% | – | – | – | |
| – | – | – | – | – | -100.0% | – | +66.7% | -100.0% | – | – | -100.0% | – | |
| – | – | – | – | – | – | – | -67.3% | – | -80.4% | -137.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -113.9% | – | +1,849.3% | -73.1% | -183.3% | – | |
| – | – | – | – | – | – | +141.3% | -172.2% | – | +44.7% | -258.8% | – | – | |
| – | – | – | – | – | – | -112.4% | – | – | – | -102.3% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.